- Home
- MNDR vs CRIS Comparison
MNDR vs CRIS Comparison
Compare MNDR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNDR | CRIS |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.0M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MNDR | CRIS |
|---|---|---|
| Price | $1.48 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 64.1K | ★ 154.2K |
| Earning Date | 10-30-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | $497.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.40 | $0.18 |
| 52 Week High | $5.42 | $6.74 |
Technical Indicators
Market Signals| Indicator | MNDR | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 17.03 |
| Support Level | $1.40 | $0.49 |
| Resistance Level | $1.53 | $0.79 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 48.41 | 3.02 |
Price Performance
Historical ComparisonAbout MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.